MICHAEL SCHEURER to Papillomavirus Infections
This is a "connection" page, showing publications MICHAEL SCHEURER has written about Papillomavirus Infections.
Connection Strength
4.286
-
Polymorphisms in the Nonhomologous End-joining DNA Repair Pathway are Associated with HPV Integration in Cervical Dysplasia. Cancer Prev Res (Phila). 2023 08 01; 16(8):461-469.
Score: 0.663
-
Mailed self-sample HPV testing kits to improve cervical cancer screening in a safety net health system: protocol for a hybrid effectiveness-implementation randomized controlled trial. Trials. 2020 Oct 21; 21(1):872.
Score: 0.547
-
Racial/ethnic differences in HPV 16/18 genotypes and integration status among women with a history of cytological abnormalities. Gynecol Oncol. 2018 02; 148(2):357-362.
Score: 0.449
-
Feasibility of Cervical Cancer Screening Utilizing Self-sample Human Papillomavirus Testing Among Mexican Immigrant Women in Harris County, Texas: A Pilot Study. J Immigr Minor Health. 2015 Jun; 17(3):704-12.
Score: 0.376
-
Nativity differences in behaviors associated with high-risk HPV infection among Hispanic women in Houston, Texas, USA. J Immigr Minor Health. 2013 Aug; 15(4):836-41.
Score: 0.331
-
Associations between human herpesvirus-6, human papillomavirus and cervical cancer. Cancer Lett. 2013 Aug 09; 336(1):18-23.
Score: 0.325
-
Human papillomavirus-related cellular changes measured by cytometric analysis of DNA ploidy and chromatin texture. Cytometry B Clin Cytom. 2007 Sep; 72(5):324-31.
Score: 0.220
-
Human papillomavirus infection: biology, epidemiology, and prevention. Int J Gynecol Cancer. 2005 Sep-Oct; 15(5):727-46.
Score: 0.191
-
A novel tailed primer nucleic acid test for detection of HPV 16, 18 and 45 DNA at the point of care. Sci Rep. 2023 11 21; 13(1):20397.
Score: 0.169
-
Self-Sampling for Human Papillomavirus Testing: Acceptability in a U.S. Safety Net Health System. Am J Prev Med. 2024 03; 66(3):540-547.
Score: 0.169
-
An integrated isothermal nucleic acid amplification test to detect HPV16 and HPV18 DNA in resource-limited settings. Sci Transl Med. 2023 06 21; 15(701):eabn4768.
Score: 0.164
-
Intravaginal practices and genital human papillomavirus infection among female sex workers in Cambodia. J Med Virol. 2018 11; 90(11):1765-1774.
Score: 0.117
-
Racial/ethnic variation in the prevalence of vaccine-related human papillomavirus genotypes. Ethn Health. 2019 10; 24(7):804-815.
Score: 0.110
-
A paper-based immunoassay to determine HPV vaccination status at the point-of-care. Vaccine. 2016 11 04; 34(46):5656-5663.
Score: 0.103
-
Acceptability of self-sample human papillomavirus testing among medically underserved women visiting the emergency department. Gynecol Oncol. 2015 Aug; 138(2):317-22.
Score: 0.094
-
Comparison of the accuracy of Hybrid Capture II and polymerase chain reaction in detecting clinically important cervical dysplasia: a systematic review and meta-analysis. Cancer Med. 2013 Jun; 2(3):367-90.
Score: 0.081
-
Epidemiologic differentiation of diagnostic and screening populations for the assessment of cervical dysplasia using optical technologies. Gend Med. 2012 Feb; 9(1 Suppl):S36-47.
Score: 0.075
-
Epidemiologic modeling of cervical dysplasia with molecular and cytopathological markers. Gynecol Oncol. 2007 Oct; 107(1 Suppl 1):S163-9.
Score: 0.055
-
A novel method for semi-quantitative detection of HPV16 and HPV18 mRNA with a low-cost, open-source fluorimeter. Anal Bioanal Chem. 2025 Apr; 417(9):1765-1778.
Score: 0.046